Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 3, 2021
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet FormulationTine A Bækdal, Astrid Breitschaft, Morten Donsmark, et al.Journal of Diabetes and Its Complications|February 25, 2014
Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trialsVivian A Fonseca, J Hans Devries, Robert R Henry, et al.Diabetes & Vascular Disease Research|December 19, 2023
Cardiovascular and renal outcomes of GLP-1 receptor agonists vs. DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: A systematic review and meta-analysisMarc Evans, Paul Kuodi, Chisom Joyqueenet Akunna, et al.Journal of Lipid Research|August 15, 2006
Decrease in intramuscular lipid droplets and translocation of HSL in response to muscle contraction and epinephrineClara Prats, Morten Donsmark, Klaus Qvortrup, et al.Diabetes Care|May 6, 2017
Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development ProgramWilliam M Steinberg, Julio Rosenstock, Thomas A Wadden, et al.Journal of Lipid Research|October 4, 2005
Transcriptome and proteome analysis of soleus muscle of hormone-sensitive lipase-null miceOla Hansson, Morten Donsmark, Charlotte Ling, et al.Clinical Pharmacokinetics|December 20, 2018
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 DiabetesCharlotte Granhall, Morten Donsmark, Thalia M Blicher, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%Allen B King, Eduard Montanya, Richard E Pratley, et al.American Journal of Physiology. Endocrinology and Metabolism|July 11, 2006
Sex differences in hormone-sensitive lipase expression, activity, and phosphorylation in skeletal muscle at rest and during exerciseCarsten Roepstorff, Morten Donsmark, Maja Thiele, et al.The Journal of Physiology|August 17, 2004
Regulation of hormone-sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exerciseCarsten Roepstorff, Bodil Vistisen, Morten Donsmark, et al.Pageof 3